Services Database Observed Consumption of Methadone (Physeptone) & Buprenorphine (Subutex)
Service ID
44618
Description
The service allows for the self-administration of prescribed methadone or buprenorphine, which is supervised and monitored daily in community pharmacies by means of a 4-way agreement between the prescriber, patient, Recovery co-ordinator and pharmacy.
Pharmacists can delegate the supervision of methadone and buprenorphine to appropriately trained staff.
Location of service
North Staffordshire & Stoke-on-Trent LPC
Commissioner
Method of commissioning
Source of funding
Service type
Supervised administration
Other organisations involved
One Recovery Staffordshire
Dates
Start date:
End date:
Status
Ongoing
Training
All lead pharmacists must complete the CPPE distance learning course “Substance Use and Misuse” OR have previously completed “Opiate treatment: Supporting pharmacists for improved patient care” before accreditation is granted. Evidence of suitable training will be recorded by the pharmacist using the CPPE Declaration of Competence (DoC) and the information provided to OneRecovery via the PharmOutcomes system (Pharmacy Sign-Up module).
Pharmacists are also encouraged to attend the local supervised consumption training event.
All pharmacy staff involved in the delivery of the harm reduction services to drug users should be encouraged to attend harm reduction training; to be updated on an annual basis as arranged by One Recovery Staffordshire. It is also advised that all new pharmacy staff attend forthcoming annual harm reduction training events.
